Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Lockdown leads to double unplanned pregnancies
Fri October 22nd - Unplanned pregnancies almost doubled during the first lockdown in the UK, a major study reports today. More
Promising development in treatment for glioblastoma multiforme
Fri October 22nd - A major advance in brain tumour research could pave the way for personalised treatment for the most deadly form of the disease, British scientists say. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

Drug-resistant bacteria spread rapidly during travel

Wednesday February 24th 2021

International travellers are a high risk for transmission of drug resistant bacteria, according to a study published today.

Scientists tracked the global spread of intestinal multidrug resistant bacteria as part of a project to measure the impact of travel on the spread of these bacteria.

The team, led by Professor Alan McNally of the University of Birmingham, UK, monitored a group of European travellers who went to Laos in Southeast Asia for three weeks.

The gut health of the participants was measured by providing stool samples and daily health updates.

This showed that certain strains of bacteria colonised multiple participants who were staying at the same hotels and socialising together. For example, one identical strain was found in two participants who used the same shower.

Writing in The Lancet Microbe today (24 February), the authors explain that international travellers appear to be particularly vulnerable to virulent strains of drug-resistant bacteria.

They write: "The global spread of intestinal multidrug resistant gram-negative (MDR-GN) bacteria poses a serious threat to human health worldwide, with multi-drug resistant clones of E.coli and Klebsiella pneumoniae threatening more antibiotic resistant infections around the world."

Professor McNally said: “International travel is strongly linked to the spread of MDR-GN bacteria, with transmission highest in India and Southeast Asia, Africa and South America. Travellers visiting these high-risk regions are at substantial risk of acquiring the bacteria.

“Colonisation by MDR-GN bacteria is a highly dynamic process. We found constant ‘competition’ between circulating strains acquired by individual hosts and the travellers’ ‘native’ bacteria. Travellers can pick up the bacteria even during short visits and further spread the strains after returning home.”

Co-author Dr Jukka Corander added that the true scale at which drug-resistant bacteria colonise the intestinal tract during travel "has been seriously underestimated previously".

Kantele, A. et al. Intestinal multidrug-resistant bacteria contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling study. The Lancet Microbe 24 February 2021


Tags: Flu & Viruses | MRSA & Hygiene | UK News | World Health

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)